WORLD AIDS DAY
Join us for The Audacity of Hope, a thought-provoking World AIDS Day webinar dedicated to providing a platform for people living with HIV to reclaim their narrative and explore the transformative power of hope.
Through open dialogue, personal stories and expert insights, this webinar will highlight the resilience, strength and worthiness of those affected by HIV, while fostering a sense of community, empowerment and optimism for the future.
Be part of this powerful conversation and help redefine the future of HIV advocacy. Whether you’re part of the HIV community or an ally, this event will inspire, educate and foster connection.
Panelists
- Paul Aguilar
- Tom Villa
- Rebecca Denison
- Moderated by Morris Singletary and Alecia Tramel-McIntyre
This event is hosted in conjunction with the San Francisco AIDS Foundation.
About the HOPE Collaboratory
The HIV Obstruction by Programmed Epigenetics (HOPE) Collaboratory is led by researchers at Gladstone Institutes, University of Florida, and Weill Cornell Medicine. It also includes members from Leibniz Institute for Experimental Virology in Germany, the US Military HIV Research Program, the University of Sao Paulo in Brazil, UC Berkeley, Buck Institute for Research on Aging, the Makerere University Walter Reed Project in Uganda, and Lakehead University in Canada. The HOPE Collaboratory is supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number UM1AI164559.
Details
Diversity, Equity, and Inclusion
At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.
We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.